.svg-6af5dfb7ccef8f01d163f9ebdf2f0df6.svg){kind=small}
Bimuno® Pet is a targeted prebiotic with unique structures and composition of galactooligosaccharides (GOS).
Bimuno® Pet feeds and stimulates the growth of beneficial bacteria in the gut which has been associated with a wide range of health benefits. As non-digestible fibre, it passes through the upper gastrointestinal tract until it reaches the large intestine, where it is utilised by beneficial bacteria. Supporting the growth of beneficial bacteria is crucial across all age ranges of pets.
In companion animals, gut health is a cornerstone of overall well-being, playing a critical role in regulating both gastrointestinal and immune systems.
Prebiotic galactooligosaccharides (GOS) offer targeted support by nourishing beneficial gut bacteria, which in turn provides various supporting actions, such as improving stool quality, reducing the occurrence of digestive issues like diarrhea and constipation. Additionally, GOS can play a key role in aiding immune function, achieved through increasing short-chain fatty acids (SCFAs) such as butyrate.
Research highlights prebiotic GOS as particularly effective in promoting the growth of essential gut bacteria such as Lachnospiraceae and Bifidobacterium spp., key to gastrointestinal health in cats and dogs, as well as Lactobacillus spp. in dogs, where it has been shown to enhance immune function1.
This makes GOS an ideal choice for addressing common digestive concerns and supporting a balanced microbiome in pets. Unlike plant-based prebiotics, dairy-derived GOS is naturally suited for cats and dogs due to their carnivore type diets1, meaning Bimuno GOS provides a species-appropriate solution that aligns with their natural needs.
The science behind Bimuno is one of the most comprehensive of any commercially available prebiotic. Bimuno GOS’ efficacy is supported by over 120 scientific publications and more than 20 clinical studies across both human and animal populations.
Its unique and patented compositional structure supports its specificity for feeding bifidobacteria in the large intestine2-17, a type of naturally occurring, beneficial intestinal bacteria. Other prebiotics may lack this selectivity and can therefore be metabolized by many types of microbes, beneficial or otherwise.
[1] Corbee, R. J. et al., (2024): [2] Tzortzis et al., 2005; [3] Depeint et al., 2008; [4] Vulevic et al., 2008; [5] Silk et al., 2009 [6] Savignac et al., 2013; [7] Vulevic et al., 2013; [8] Costabile et al., 2015; [9] Vulevic et al., 2015; [10] Grimaldi et al., 2016; [11] Savignac et al., 2016; [12] Liu et al., 2016; [13] Grimaldi et al., 2017; [14] Grimaldi et al., 2018; [15] Huaman et al., 2018; [16] Kao et al., 2019; [17] Wilson et al., 2021; [18] Biagi et al., 2013; [19] Ogué-Bon et al., 2010 [20] Kanakupt et al., 2011; [21] Le Bon et al,. 2023; [22] Perini et al., 2023; [23] Rentas et al., 2020 ; [24] Abecia et al., 2010.
Bimuno® is a trademark of Clasado Limited.